116 related articles for article (PubMed ID: 7739367)
1. In vivo relaxation time measurements on a murine tumor model--prolongation of T1 after photodynamic therapy.
Liu YH; Hawk RM; Ramaprasad S
Magn Reson Imaging; 1995; 13(2):251-8. PubMed ID: 7739367
[TBL] [Abstract][Full Text] [Related]
2. In vivo resistance to photofrin-mediated photodynamic therapy in radiation-induced fibrosarcoma cells resistant to in vitro Photofrin-mediated photodynamic therapy.
Adams K; Rainbow AJ; Wilson BC; Singh G
J Photochem Photobiol B; 1999 Apr; 49(2-3):136-41. PubMed ID: 10392463
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.
Qiu H; Kim MM; Penjweini R; Finlay JC; Busch TM; Wang T; Guo W; Cengel KA; Simone CB; Glatstein E; Zhu TC
Photochem Photobiol; 2017 Jul; 93(4):1115-1122. PubMed ID: 28083883
[TBL] [Abstract][Full Text] [Related]
4. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
5. Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model.
Cheung R; Solonenko M; Busch TM; Del Piero F; Putt ME; Hahn SM; Yodh AG
J Biomed Opt; 2003 Apr; 8(2):248-52. PubMed ID: 12683850
[TBL] [Abstract][Full Text] [Related]
6. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model.
Henderson BW; Fingar VH
Photochem Photobiol; 1989 Mar; 49(3):299-304. PubMed ID: 2525260
[TBL] [Abstract][Full Text] [Related]
7. Effect of photodynamic therapy on RIF-1 tumor metabolism and blood flow examined by 31P and 2H NMR spectroscopy.
Mattiello J; Evelhoch JL; Brown E; Schaap AP; Hetzel FW
NMR Biomed; 1990 Apr; 3(2):64-70. PubMed ID: 2390455
[TBL] [Abstract][Full Text] [Related]
8. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
Sitnik TM; Henderson BW
Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice.
Anderson CY; Freye K; Tubesing KA; Li YS; Kenney ME; Mukhtar H; Elmets CA
Photochem Photobiol; 1998 Mar; 67(3):332-6. PubMed ID: 9523532
[TBL] [Abstract][Full Text] [Related]
10. Changes in perfusion of mouse tumours after photodynamic therapy.
van Geel IP; Oppelaar H; Oussoren YG; Stewart FA
Int J Cancer; 1994 Jan; 56(2):224-8. PubMed ID: 8314306
[TBL] [Abstract][Full Text] [Related]
11.
Penjweini R; Kim MM; Ong YH; Zhu TC
Phys Med Biol; 2020 Jan; 65(3):03LT01. PubMed ID: 31751964
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermic potentiation of photodynamic therapy employing Photofrin I and II: comparison of results using three animal tumor models.
Waldow SM; Henderson BW; Dougherty TJ
Lasers Surg Med; 1987; 7(1):12-22. PubMed ID: 2952850
[TBL] [Abstract][Full Text] [Related]
13. Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome.
Wang HW; Putt ME; Emanuele MJ; Shin DB; Glatstein E; Yodh AG; Busch TM
Cancer Res; 2004 Oct; 64(20):7553-61. PubMed ID: 15492282
[TBL] [Abstract][Full Text] [Related]
14. Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.
Busch TM; Xing X; Yu G; Yodh A; Wileyto EP; Wang HW; Durduran T; Zhu TC; Wang KK
Photochem Photobiol Sci; 2009 Dec; 8(12):1683-93. PubMed ID: 20024165
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen.
Busch TM; Wileyto EP; Emanuele MJ; Del Piero F; Marconato L; Glatstein E; Koch CJ
Cancer Res; 2002 Dec; 62(24):7273-9. PubMed ID: 12499269
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence.
Zaidi SI; Oleinick NL; Zaim MT; Mukhtar H
Photochem Photobiol; 1993 Dec; 58(6):771-6. PubMed ID: 8309997
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model.
Chen B; Roskams T; Xu Y; Agostinis P; de Witte PA
Int J Cancer; 2002 Mar; 98(2):284-90. PubMed ID: 11857421
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy of photofrin II and excimer dye laser on experimental tumors.
Tanaka M; Uchibayashi T; Obata T; Sasaki T
Cancer Lett; 1995 Apr; 90(2):163-9. PubMed ID: 7736452
[TBL] [Abstract][Full Text] [Related]
19. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
[TBL] [Abstract][Full Text] [Related]
20. Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy.
Cecic I; Stott B; Korbelik M
Int Immunopharmacol; 2006 Aug; 6(8):1259-66. PubMed ID: 16782538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]